Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor

Circulation Research

Volumn 85, Issue 10, 1999, Pages 906-911

  Fernandez Patron, Carlos ^a   Radomski, Marek W ^a   Davidge, Sandra T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Endothelin; Metalloproteinase; Vasculature

Indexed keywords

ENDOTHELIN 1; GELATINASE A;

AMINO ACID SEQUENCE; ANGIOGENESIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; MESENTERIC ARTERY; PRIORITY JOURNAL; VASOCONSTRICTION;

EID: 0032719798     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.10.906     Document Type: Article

References (30)

1. Parks WC, Mecham RP, eds. Matrix Metalloproteinases. San Diego, Calif: Academic Press; 1998.
2. Ray JM, Stetler-Stevenson WG. The role of metalloproteinases and their inhibitors in tumor, metastasis, and angiogenesis. Eur Respir J. 1994;7: 2062-2072.
3. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opinion Cell Biol. 1995;7:728-735.
4. Li Z, Froehlich J, Galis ZS, Lakatta EG. Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. HypertenSion. 1999;33:116-123.
5. Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase: inhibitor-free enzyme catalyzes the cleavage of type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem. 1995; 270:5872-5876.
6. Gianelli G, Falk-Marzillier J, Shiraldi O, Stetler-Stevenson W, Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science. 1997;277:225-228.
7. Sawicki G, Salas E, Murat J, Miszta-Lane H, Radomski, MW. Release of gelantinase A during platelet activation mediates aggregation. Nature. 1997;386:616-619.
8. Tanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui, Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
9. Yu JC, Davenport AP. Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells. Br J Pharmacol. 1995; 114:551-557.
10. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, de Wit D, Yanagisawa M. ECE-1 a membrane-bound metalloprotease that catalyzes the proteolytic activition of big endothelin-1. Cell. 1994;78:473-485.
11. Opgenort TJ, Wu-Wong JR, Shiosaki K. Endothelin-converting enzymes. FASEB J. 1992;6:2653-2659.
12. McMahon EG, Palomo MA, Moore WM, McDonald JF, Stern MK. Phosphoramidon blocks the pressor activity of porcine big endothelin-1 (1-39) in vivo and conversion of big endothelin-1 (1-39) to endothelin-1 (1-21) in vitro. Proc Natl Acad Sci U S A. 1991;88:703-707.
13. Kimura S, Kasuya Y, Sawamura T, Osamu S, Yoshiki S, Yanagisawa M, Goto K, Masaki T. Conversion of big endothelin-1 to 21-residue endothelin-1 is essential for expression of full vasoconstrictor activity: structure-activity relationships of big endothelin-1. J Cardiovasc Pharmacol. 1989;13(suppl 5):S5-S7.
14. Patterson K, MacNaul R, Rubanyi GM, Parker-Botello LH. Separation and biological activity of the chymotrypsin and cathepsin G cleavage Products of big endothelin (1-39). FASEB J. 1990;4:A909. Abstract.
15. Kaw S, Hecker M, Vane JR. The two step conversion of big endothelin 1 to endothelin 1 by subcellular fractions from human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A. 1992;89:6886-6890.
16. Ahn K, Sisneros AM, Herman SB, Pan SM, Hupe D, Lee C, Nikam S, Cheng X, Doherty AM, Schroeder RL, Haleen SJ, Kaw S, Emoto N, Yanajisaw, M. Novel selective quinazoline inhibitors of endothelin converting enzyme-1. Biochem Biophys Res Commun. 1998;243: 184-190.
17. Emoto N, Yanagisawa M. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon sensitive metalloprotease with acidic pH optimum. J Biol Chem. 1995;270:15262-15268.
18. Kishi F, Minami K, Okishima N, Murakami M, Mon S, Yano M, Niwa Y, Nakaya Y, Kido H. Novel 31-amino-acid-length endothelins cause constriction of vascular smooth muscle. Biochem, Biophys Res Commun. 1998;248:387-390.
19. Galis ZS, Sukhova GK, Libby P. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J. 1995;9:974-980.
20. Osol GC, Cipolla M, Knutson S. A new method for mechanically denuding the endothelium of small (50-150 μm) arteries with a human hair. Blood Vessels. 1989;26:320-324.
21. Hingorani G, Major T, Panek R, Flynn M, Reynolds E, He X, Cody W, Doherty A, Rapundalo S. In vitro pharmacology of a non-selective (ETA/ETB) endothelin receptor antagonist, PD 142893 (Ac-(β-phenyl)D-Phe-L-Leu-L-Asp-L-Ile-Ile-L-Trp trifluoroacetate). FASEB J. 1992;6: A1003. Abstract.
22. Battistini B, Chailler P, D'Orleans-Juste P, Briere N, Sirois P. Growth regulatory properties of endothelins. Peptides. 1993;14:385-399.
23. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46:325-415.
24. Ishibashi M, Ito N, Fujita M, Furue H, Yamaji T. Endothelin-1 as an aggravating factor of diseminated intravascular coagulation associated with, malignant neoplasms. Cancer. 1994;73:191-195.
25. Jenkins GM, Crow MT, Bilato C, Gluzband Y, Ryu WS, Li Z, Stetler-Stevenson W, Nater C, Froehlich JP, Lakatta EG, Cheng L. Increased expression of membrane-type matrix metalloproteinase and preferential localization of matrix metalloproteinase-2 to the neointima of balloon-injured rat carotid arteries. Circulation. 1998;97:82-90.
26. Newby AC, Southgate KM, Davies M. Extracelluiar matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis. Basic Res Cardiol. 1993;89:59-70.
27. Libby P, Geng Y-J, Sukhova GK, Simon DI, Lee RT, Alexander RW, Clowes A, Tanaka K, Fuster V, Kume N, Suzuki A. Molecular determinants of atherosclerotic plaque vulnerability. Ann N Y Acad Sci 1997; 811:134-145.
28. Kirchegast M, Muenter K. Endothelins and restenosis. Cardiovasc Res. 1998;39:550-555.
29. Libby P, Tanaka H. The molecular basis of restenosis. Prog Cardiovasc Dis. 1997;40:97-106.
30. Fernandez-Patron C, Zhang Y, Radomski MW, Hollenberg MD, Davidge ST. Rapid release of matrix metalloproteinase (MMP)-2 by thrombin in the rat aorta: modulation by protein tyrosine kinase/phosphatase. Thromb Haemost. 1999;82:1353-1357.